drugset / Trial / NCT00919815
Ciclosporin in the Management of New Type 1 Reactions in Leprosy
Phase 2/3
Completed
73 enrolled
London School of Hygiene and Tropical Medicine
Alert Hospital, Ethiopia · collabArmauer Hansen Research Institute, Ethiopia · collabHomes and Hospitals of St Giles · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Study 1A: Ciclosporin in the management of new Type 1 Reactions in Leprosy Objective: A randomised double blind controlled trial comparing Ciclosporin and Prednisolone,to determine whether treatment with Ciclosporin gives the same outcome in the treatment of new Type 1 Reactions as Prednisolone.
Timeline
- Start
- 2010-08
- Primary completion
- 2012-12
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 7.5 mg/kg | — |
| Comparator | Prednisolone | Other / unclassified | 40 mg | — |